NovoCure Aktie

15,93 EUR -0,03 EUR -0,19 %

30.04.2025

STU

17,95 USD -0,18 USD -0,97 %

21:59:57

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.1,79 Mrd. EUR

Div. Rendite0,00%

WKNA140ML

ISINJE00BYSS4X48

SymbolNVCR

NovoCure Aktien News

Sortieren:Datum Meistgelesen

24.06.23PR NewswireNOVOCURE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Again...

24.06.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

21.06.23PR NewswireCalling all investors in NovoCure Limited (NVCR): New lawsuit lead plaintiff deadline is August 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC today

16.06.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

07.06.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR

01.06.23BusinesswireNovocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education

05.05.23finanzen.netNovoCure gab Ergebnis zum abgelaufenen Quartal bekannt

04.05.23BusinesswireNovocure Reports First Quarter 2023 Financial Results

03.05.23finanzen.netAusblick: NovoCure stellt das Zahlenwerk zum vergangenen Quartal vor

26.04.23BusinesswireNovocure Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

19.04.23finanzen.netErste Schätzungen: NovoCure legt Zahlen zum jüngsten Quartal vor

14.04.23BusinesswireNovocure Announces 27 Presentations, Including Real-World Evidence and Preclinical Research, at American Association for Cancer Research (AACR) Annual Meeting 2023

03.04.23BusinesswireNovocure to Report First Quarter 2023 Financial Results

29.03.23BusinesswireKristin Stafford Joins Novocure Board of Directors

16.03.23BusinesswireNovocure Announces 5th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program

01.03.23BusinesswireNovocure Announces Reimbursement of Optune® for the Treatment of Newly Diagnosed Glioblastoma in France

01.03.23BusinesswireNovocure Announces Last Patient Enrolled in Pivotal METIS Study of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung Cancer

24.02.23finanzen.netNovoCure verkündete Quartalsergebnis zum jüngsten Jahresviertel

23.02.23BusinesswireAllyson J. Ocean, M.D., Joins Novocure Board of Directors

23.02.23BusinesswireNovocure Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update

22.02.23finanzen.netAusblick: NovoCure präsentiert Bilanzzahlen zum jüngsten Jahresviertel

15.02.23BusinesswireNovocure Announces Last Patient Enrolled in Pivotal PANOVA-3 Study of Tumor Treating Fields in Pancreatic Cancer

08.02.23finanzen.netErste Schätzungen: NovoCure mit Zahlen zum abgelaufenen Quartal

19.01.23BusinesswireNovocure Announces Organizational Changes to Prepare for Future Growth

10.01.23BusinesswireNovocure: LUNAR-Studie erreicht primären Endpunkt für Gesamtüberleben bei nicht kleinzelligem Lungenkrebs

09.01.23BusinesswireNovocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company Update

05.01.23BusinesswireNovocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint

27.12.22BusinesswireNovocure to Participate in 41st Annual J.P. Morgan Healthcare Conference

29.11.22BusinesswireNovocure’s Optune® Approved in Canada for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

23.11.22BusinesswireNovocure to Participate in 34th Annual Piper Sandler Healthcare Conference

17.11.22BusinesswireNovocure Announces 25 Abstracts on Tumor Treating Fields Therapy at Society for Neuro-Oncology 2022 Annual Meeting

15.11.22BusinesswireNovocure Opens Office in Montreal to Expand and Support Growing Business in Canada

11.11.22BusinesswireNovocure Secures CE Mark for New Array

28.10.22finanzen.netNovoCure öffnete die Bücher zum abgelaufenen Quartal

27.10.22BusinesswireNovocure Reports Third Quarter 2022 Financial Results

26.10.22finanzen.netAusblick: NovoCure legt Quartalsergebnis vor

22.10.22BusinesswireNovocure Announces 11 Presentations on Tumor Treating Fields in Multiple Solid Tumor Types at the American Society for Radiation Oncology 2022 Annual Meeting

20.10.22BusinesswireNovocure Announces Review Article of Anti-Cancer Mechanisms of Action of Tumor Treating Fields Published in Journal of Molecular Cell Biology

20.10.22BusinesswireNovocure Launches Campaign to Drive Awareness and Understanding of Tumor Treating Fields Therapy

12.10.22finanzen.netErste Schätzungen: NovoCure stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor

NovoCure News

NovoCure News: auf dieser Seite finden Sie alle NovoCure News und Nachrichten zur NovoCure Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch NovoCure News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um NovoCure News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.